{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:53:27Z","timestamp":1794448407549,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"AOP ORPHAN PHARMACEUTICALS GmbH - Member of the AOP Health Group"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-06200-9","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:33:59Z","timestamp":1786113239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of landiolol in septic shock patients with new onset of atrial fibrillation: a European Delphi consensus"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2562-0199","authenticated-orcid":false,"given":"Fabio","family":"Guarracino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Balik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demosthenes","family":"Makris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rehberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Slama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"6200_CR1","doi-asserted-by":"publisher","unstructured":"V\u00e9lez-Gim\u00f3n M. Atrial fibrillation during septic shock. Infections Sepsis Dev. 2021;359. https:\/\/doi.org\/10.5772\/intechopen.100317.","DOI":"10.5772\/intechopen.100317"},{"issue":"Suppl 1","key":"6200_CR2","doi-asserted-by":"publisher","first-page":"A13806","DOI":"10.1161\/circ.144.suppl_1.13806","volume":"144","author":"MR Vindhyal","year":"2021","unstructured":"Vindhyal MR, Vasudeva R, Pothuru S, Ablah E, Choi W, Kallail K, et al. In-hospital outcomes among patients with septic shock and underlying chronic atrial fibrillation. Circulation. 2021;144(Suppl 1):A13806. https:\/\/doi.org\/10.1161\/circ.144.suppl_1.13806.","journal-title":"Circulation"},{"issue":"2","key":"6200_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/CCM.0000000000003560","volume":"47","author":"NA Bosch","year":"2019","unstructured":"Bosch NA, Cohen DM, Walkey AJ. Risk Factors for New-Onset Atrial Fibrillation in Patients With Sepsis: A Systematic Review and Meta-Analysis. Crit Care Med. 2019;47(2):280\u20137. https:\/\/doi.org\/10.1097\/CCM.0000000000003560.","journal-title":"Crit Care Med"},{"issue":"4","key":"6200_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1515\/jccm-2015-0027","volume":"1","author":"A Schwartz","year":"2015","unstructured":"Schwartz A, Brotfain E, Koyfman L, Klein M. Cardiac Arrhythmias in a Septic ICU Population: A Review. J Crit Care Med. 2015;1(4):140\u20136. https:\/\/doi.org\/10.1515\/jccm-2015-0027.","journal-title":"J Crit Care Med"},{"issue":"5","key":"6200_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/08850666221131778","volume":"38","author":"MR Vindhyal","year":"2023","unstructured":"Vindhyal MR, Vasudeva R, Pothuru S, Kallail K, Choi W, Ablah E, et al. In-hospital Outcomes of Patients with Septic Shock and Underlying Chronic Atrial Fibrillation: A Propensity Matched Analysis from A National Dataset. J Intensive Care Med. 2023;38(5):425\u201330. https:\/\/doi.org\/10.1177\/08850666221131778.","journal-title":"J Intensive Care Med"},{"issue":"2","key":"6200_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12471-014-0641-x","volume":"23","author":"S Gandhi","year":"2015","unstructured":"Gandhi S, Litt D, Narula N. New-onset atrial fibrillation in sepsis is associated with increased morbidity and mortality. Neth Heart J. 2015;23(2):82\u20138. https:\/\/doi.org\/10.1007\/s12471-014-0641-x.","journal-title":"Neth Heart J"},{"issue":"3","key":"6200_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5152\/tjar.2019.44789","volume":"47","author":"I Steinberg","year":"2019","unstructured":"Steinberg I, Brogi E, Pratali L, Trunfio D, Giuliano G, Bignami E, et al. Atrial Fibrillation in Patients with Septic Shock: A One-Year Observational Pilot Study. Turk J Anaesthesiol Reanim. 2019;47(3):213\u20139. https:\/\/doi.org\/10.5152\/tjar.2019.44789.","journal-title":"Turk J Anaesthesiol Reanim"},{"key":"6200_CR8","doi-asserted-by":"publisher","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498. doi: 10.1093\/eurheartj\/ehaa612. Erratum in: Eur Heart J. 2021;42(5):507. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa798. Erratum in: Eur Heart J. 2021;42(5):546-7. doi: 10.1093\/eurheartj\/ehaa945. Erratum in: Eur Heart J. 2021;42(40):4194. doi: 10.1093\/eurheartj\/ehab648.","DOI":"10.1093\/eurheartj\/ehaa798"},{"issue":"36","key":"6200_CR9","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314\u2013414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176.","journal-title":"Eur Heart J"},{"issue":"10","key":"6200_CR10","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s00134-025-08112-8","volume":"51","author":"M Balik","year":"2025","unstructured":"Balik M, Vignon P, Chew MS, Tavazzi G, Mayo P, Doufle G, et al. Echocardiography guided management of atrial fibrillation. Intensive Care Med. 2025;51(10):1855\u201366. https:\/\/doi.org\/10.1007\/s00134-025-08112-8.","journal-title":"Intensive Care Med"},{"issue":"1","key":"6200_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s44158-023-00126-2","volume":"3","author":"F Guarracino","year":"2023","unstructured":"Guarracino F, Cortegiani A, Antonelli M, Behr A, Biancofiore G, Del Gaudio A, et al. The role of beta-blocker drugs in critically ill patients: a SIAARTI expert consensus statement. J Anesth Analg Crit Care. 2023;3(1):41. https:\/\/doi.org\/10.1186\/s44158-023-00126-2.","journal-title":"J Anesth Analg Crit Care"},{"issue":"4","key":"6200_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1253\/circj.cj-12-1618","volume":"77","author":"R Nagai","year":"2013","unstructured":"Nagai R, Kinugawa K, Inoue H, Atarashi H, Seino Y, Yamashita T, et al. Urgent management of rapid heart rate in patients with atrial fibrillation\/flutter and left ventricular dysfunction: comparison of the ultra-short-acting \u03b21-selective blocker landiolol with digoxin (J-Land Study). Circ J. 2013;77(4):908\u201316. https:\/\/doi.org\/10.1253\/circj.cj-12-1618.","journal-title":"Circ J"},{"issue":"Suppl A","key":"6200_CR13","doi-asserted-by":"publisher","first-page":"A15","DOI":"10.1093\/eurheartj\/sux039","volume":"20","author":"S Rehberg","year":"2018","unstructured":"Rehberg S, Joannidis M, Whitehouse T, Morelli A. Landiolol for managing atrial fibrillation in intensive care. Eur Heart J Suppl. 2018;20(Suppl A):A15\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/sux039.","journal-title":"Eur Heart J Suppl"},{"issue":"10","key":"6200_CR14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00134-024-07587-1","volume":"50","author":"S Rehberg","year":"2024","unstructured":"Rehberg S, Frank S, \u010cern\u00fd V, Cihlar R, Borgstedt R, Biancofiore G, et al. Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med. 2024;50(10):1622\u201334. https:\/\/doi.org\/10.1007\/s00134-024-07587-1.","journal-title":"Intensive Care Med"},{"issue":"3","key":"6200_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5492\/wjccm.v4.i3.251","volume":"4","author":"M Okajima","year":"2015","unstructured":"Okajima M, Takamura M, Taniguchi T. Landiolol, an ultra-short-acting \u03b21-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis. World J Crit Care Med. 2015;4(3):251\u20137. https:\/\/doi.org\/10.5492\/wjccm.v4.i3.251.","journal-title":"World J Crit Care Med"},{"key":"6200_CR16","doi-asserted-by":"publisher","unstructured":"Dan GA, Dan AR, Ivanescu A, Buzea AC. Acute rate control in atrial fibrillation: an urgent need for the clinician. Eur Heart J Suppl. 2022;24 Suppl D:D3-D10. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suac022","DOI":"10.1093\/eurheartjsupp\/suac022"},{"issue":"9","key":"6200_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","volume":"8","author":"Y Kakihana","year":"2020","unstructured":"Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, et al. Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respiratory Med. 2020;8(9):863\u201372. https:\/\/doi.org\/10.1016\/S2213-2600(20)30037-0.","journal-title":"Lancet Respiratory Med"},{"issue":"1","key":"6200_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00134-024-07706-y","volume":"51","author":"V Vazgiourakis","year":"2025","unstructured":"Vazgiourakis V, Mantzarlis K, Makris D. Landiolol in patients with septic shock. Intensive Care Med. 2025;51(1):221. https:\/\/doi.org\/10.1007\/s00134-024-07706-y.","journal-title":"Intensive Care Med"},{"issue":"1","key":"6200_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40635-019-0263-0","volume":"7","author":"TT Tran","year":"2019","unstructured":"Tran TT, Mathieu C, Torres M, Loriod B, L\u00ea LT, Nguyen C, et al. Effect of landiolol on sex-related transcriptomic changes in the myocardium during sepsis. Intensive Care Med Exp. 2019;7(1):50. https:\/\/doi.org\/10.1186\/s40635-019-0263-0.","journal-title":"Intensive Care Med Exp"},{"key":"6200_CR20","doi-asserted-by":"publisher","first-page":"100571","DOI":"10.1016\/j.eclinm.2020.100571","volume":"28","author":"N Matsuda","year":"2020","unstructured":"Matsuda N, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, et al. Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study. EClinicalMedicine. 2020;28:100571. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100571.","journal-title":"EClinicalMedicine"},{"issue":"10","key":"6200_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1253\/circrep.CR-19-0076","volume":"1","author":"N Iwahashi","year":"2019","unstructured":"Iwahashi N, Takahashi H, Abe T, Okada K, Akiyama E, Matsuzawa Y, et al. Urgent Control of Rapid Atrial Fibrillation by Landiolol in Patients With Acute Decompensated Heart Failure With Severely Reduced Ejection Fraction. Circulation Rep. 2019;1(10):422\u201330. https:\/\/doi.org\/10.1253\/circrep.CR-19-0076.","journal-title":"Circulation Rep"},{"issue":"1","key":"6200_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jjcc.2021.09.008","volume":"79","author":"N Iwahashi","year":"2022","unstructured":"Iwahashi N, Kirigaya J, Abe T, Horii M, Takahashi H, Hanajima Y, et al. Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment. J Cardiol. 2022;79(1):21\u20139. https:\/\/doi.org\/10.1016\/j.jjcc.2021.09.008.","journal-title":"J Cardiol"},{"issue":"1","key":"6200_CR23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ehf2.13763","volume":"9","author":"V Ditali","year":"2022","unstructured":"Ditali V, Garatti L, Morici N, Villanova L, Colombo C, Oliva F, et al. Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series. ESC Heart Fail. 2022;9(1):766\u201370. https:\/\/doi.org\/10.1002\/ehf2.13763.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"6200_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/pharmaceutics16040517","volume":"16","author":"M Floria","year":"2024","unstructured":"Floria M, Oancea AF, Morariu PC, Burlacu A, Iov DE, Chiriac CP, et al. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting \u03b21 Selective Antagonist) in Atrial Fibrillation. Pharmaceutics. 2024;16(4):517. https:\/\/doi.org\/10.3390\/pharmaceutics16040517.","journal-title":"Pharmaceutics"},{"key":"6200_CR25","doi-asserted-by":"publisher","first-page":"840615","DOI":"10.1155\/2014\/840615","volume":"2014","author":"M Arrigo","year":"2014","unstructured":"Arrigo M, Bettex D, Rudiger A. Management of atrial fibrillation in critically ill patients. Crit Care Res Pract. 2014;2014:840615. https:\/\/doi.org\/10.1155\/2014\/840615.","journal-title":"Crit Care Res Pract"},{"key":"6200_CR26","doi-asserted-by":"publisher","first-page":"103114","DOI":"10.1016\/j.iccn.2021.103114","volume":"67","author":"JP Bedford","year":"2021","unstructured":"Bedford JP, Ede J, Watkinson PJ. Triggers for new-onset atrial fibrillation in critically ill patients. Intensive Crit Care Nurs. 2021;67:103114. https:\/\/doi.org\/10.1016\/j.iccn.2021.103114.","journal-title":"Intensive Crit Care Nurs"},{"issue":"1","key":"6200_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2052-0492-2-16","volume":"2","author":"T Hifumi","year":"2014","unstructured":"Hifumi T, Kato H, Koido Y, Kawakita K, Kuroda Y. Safety and effective use of landiolol in the ICU. J Intensive Care. 2014;2(1):16. https:\/\/doi.org\/10.1186\/2052-0492-2-16.","journal-title":"J Intensive Care"},{"issue":"10","key":"6200_CR28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1164\/rccm.201110-1820OC","volume":"185","author":"F Schortgen","year":"2012","unstructured":"Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, et al. Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med. 2012;185(10):1088\u201395. https:\/\/doi.org\/10.1164\/rccm.201110-1820OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"6200_CR29","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.chest.2018.03.040","volume":"154","author":"NA Bosch","year":"2018","unstructured":"Bosch NA, Cimini J, Walkey AJ. Atrial Fibrillation in the ICU. Chest. 2018;154(6):1424\u201334. https:\/\/doi.org\/10.1016\/j.chest.2018.03.040.","journal-title":"Chest"},{"issue":"1","key":"6200_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/europace\/euy110","volume":"21","author":"G Boriani","year":"2019","unstructured":"Boriani G, Fauchier L, Aguinaga L, Beattie JM, Blomstrom Lundqvist C, Cohen A, et al. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). Europace. 2019;21(1):7\u20138. https:\/\/doi.org\/10.1093\/europace\/euy110.","journal-title":"Europace"},{"issue":"3","key":"6200_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/ejechocard\/jeq176","volume":"12","author":"P Marchese","year":"2011","unstructured":"Marchese P, Bursi F, Delle Donne G, Malavasi V, Casali E, Barbieri A, et al. Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion. Eur J Echocardiogr. 2011;12(3):214\u201321. https:\/\/doi.org\/10.1093\/ejechocard\/jeq176.","journal-title":"Eur J Echocardiogr"},{"issue":"8","key":"6200_CR32","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/aas.14262","volume":"67","author":"AS Andreasen","year":"2023","unstructured":"Andreasen AS, Wetterslev M, Sigurdsson MI, Bove J, Kjaergaard J, Aslam TN, et al. New-onset atrial fibrillation in critically ill adult patients-an SSAI clinical practice guideline. Acta Anaesthesiol Scand. 2023;67(8):1110\u20137. https:\/\/doi.org\/10.1111\/aas.14262.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"6200_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.23736\/S0375-9393.20.14613-3","volume":"87","author":"F Guarracino","year":"2021","unstructured":"Guarracino F, Bertini P, Pinsky MR. Management of cardiovascular insufficiency in ICU: the BEAT approach. Minerva Anestesiol. 2021;87(4):476\u201380. https:\/\/doi.org\/10.23736\/S0375-9393.20.14613-3.","journal-title":"Minerva Anestesiol"},{"key":"6200_CR34","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00134-025-08137-z","volume":"51","author":"X Monnet","year":"2025","unstructured":"Monnet X, Messina A, Greco M, Bakker J, Aissaoui N, Cecconi M, et al. ESICM guidelines on circulatory shock and hemodynamic monitoring 2025. Intensive Care Med. 2025;51:1971\u20132012. https:\/\/doi.org\/10.1007\/s00134-025-08137-z.","journal-title":"Intensive Care Med"},{"issue":"1","key":"6200_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13054-019-2414-9","volume":"23","author":"F Guarracino","year":"2019","unstructured":"Guarracino F, Bertini P, Pinsky MR. Cardiovascular determinants of resuscitation from sepsis and septic shock. Crit Care. 2019;23(1):118. https:\/\/doi.org\/10.1186\/s13054-019-2414-9.","journal-title":"Crit Care"},{"issue":"11","key":"6200_CR36","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1097\/CCM.0000000000001257","volume":"43","author":"M Arrigo","year":"2015","unstructured":"Arrigo M, Jaeger N, Seifert B, Spahn DR, Bettex D, Rudiger A. Disappointing Success of Electrical Cardioversion for New-Onset Atrial Fibrillation in Cardiosurgical ICU Patients. Crit Care Med. 2015;43(11):2354\u20139. https:\/\/doi.org\/10.1097\/CCM.0000000000001257.","journal-title":"Crit Care Med"},{"issue":"6","key":"6200_CR37","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.ajem.2020.02.027","volume":"38","author":"M Arrigo","year":"2020","unstructured":"Arrigo M, Mebazaa A, Bettex D, Rudiger A. Hemodynamic response of restoring sinus rhythm in critically ill patients with atrial fibrillation. Am J Emerg Med. 2020;38(6):1192\u20134. https:\/\/doi.org\/10.1016\/j.ajem.2020.02.027.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"6200_CR38","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/j.jvca.2015.09.007","volume":"30","author":"SC Shibata","year":"2016","unstructured":"Shibata SC, Uchiyama A, Ohta N, Fujino Y. Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients. J Cardiothorac Vasc Anesth. 2016;30(2):418\u201322. https:\/\/doi.org\/10.1053\/j.jvca.2015.09.007.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"6200_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/bja\/aex231","volume":"119","author":"C Fuchs","year":"2017","unstructured":"Fuchs C, Wauschkuhn S, Scheer C, Vollmer M, Meissner K, Kuhn SO, et al. Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days. Br J Anaesth. 2017;119(4):616\u201325. https:\/\/doi.org\/10.1093\/bja\/aex231.","journal-title":"Br J Anaesth"},{"issue":"7","key":"6200_CR40","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s00134019-05633-x","volume":"45","author":"M Wetterslev","year":"2019","unstructured":"Wetterslev M, Haase N, Hassager C, Belley-Cote EP, McIntyre WF, An Y, et al. New-onset atrial fibrillation in adult critically ill patients: a scoping review. Intensive Care Med. 2019;45(7):928\u201338. https:\/\/doi.org\/10.1007\/s00134019-05633-x.","journal-title":"Intensive Care Med"},{"issue":"4","key":"6200_CR41","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/SHK.0000000000001905","volume":"57","author":"MN Cocchi","year":"2022","unstructured":"Cocchi MN, Dargin J, Chase M, Patel PV, Grossestreuer A, Balaji L, et al. Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial. Shock. 2022;57(4):508\u201317. https:\/\/doi.org\/10.1097\/SHK.0000000000001905.","journal-title":"Shock"},{"key":"6200_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40814-018-0321-5","volume":"4","author":"SM Brown","year":"2018","unstructured":"Brown SM, Beesley SJ, Lanspa MJ, Grissom CK, Wilson EL, Parikh SM, et al. Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study. Pilot Feasibility Stud. 2018;4:132. https:\/\/doi.org\/10.1186\/s40814-018-0321-5.","journal-title":"Pilot Feasibility Stud"},{"issue":"1","key":"6200_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13054-020-03445-w","volume":"25","author":"B Levy","year":"2021","unstructured":"Levy B, Fritz C, Piona C, Duarte K, Morelli A, Guerci P, et al. Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study. Crit Care. 2021;25(1):21. https:\/\/doi.org\/10.1186\/s13054-020-03445-w.","journal-title":"Crit Care"},{"issue":"1","key":"6200_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/j.jvca.2018.09.039","volume":"33","author":"B O\u2019Brien","year":"2019","unstructured":"O\u2019Brien B, Burrage PS, Ngai JY, Prutkin JM, Huang CC, Xu X, et al. Society of Cardiovascular Anesthesiologists\/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019;33(1):12\u201326. https:\/\/doi.org\/10.1053\/j.jvca.2018.09.039.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"6200_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1253\/circrep.CR-20-0119","volume":"3","author":"T Yamashita","year":"2020","unstructured":"Yamashita T, Nakasu Y, Mizutani H, Sumitani K. Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation\/Atrial Flutter Patients With Chronic Heart Failure - A Prospective Observational Survey (AF-CHF Landiolol Survey). Circ Rep. 2020;3(1):34\u201343. https:\/\/doi.org\/10.1253\/circrep.CR-20-0119.","journal-title":"Circ Rep"},{"issue":"4","key":"6200_CR46","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s12325-014-0111-2","volume":"31","author":"K Kinugawa","year":"2014","unstructured":"Kinugawa K, Nagai R, Inoue H, Atarashi H, Seino Y, Yamashita T, et al. Impacts of patient characteristics on the effectiveness of landiolol in AF\/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study. Adv Ther. 2014;31(4):426\u201339. https:\/\/doi.org\/10.1007\/s12325-014-0111-2.","journal-title":"Adv Ther"},{"issue":"9","key":"6200_CR47","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"SS Naidu","year":"2022","unstructured":"Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022;79(9):933\u201346. https:\/\/doi.org\/10.1016\/j.jacc.2022.01.018.","journal-title":"J Am Coll Cardiol"},{"key":"6200_CR48","doi-asserted-by":"publisher","first-page":"1263482","DOI":"10.3389\/fcvm.2023.1263482","volume":"10","author":"G Schurtz","year":"2023","unstructured":"Schurtz G, Mewton N, Lemesle G, Delmas C, Levy B, Puymirat E, et al. Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion. Front Cardiovasc Med. 2023;10:1263482. https:\/\/doi.org\/10.3389\/fcvm.2023.1263482.","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"6200_CR49","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.3390\/jcm13102951","volume":"13","author":"B Levy","year":"2024","unstructured":"Levy B, Slama M, Lakbar I, Maizel J, Kato H, Leone M, et al. Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review. J Clin Med. 2024;13(10):2951. https:\/\/doi.org\/10.3390\/jcm13102951.","journal-title":"J Clin Med"},{"issue":"6","key":"6200_CR50","doi-asserted-by":"publisher","first-page":"R198","DOI":"10.1186\/cc9317","volume":"14","author":"M Noveanu","year":"2010","unstructured":"Noveanu M, Breidthardt T, Reichlin T, Gayat E, Potocki M, Pargger H, et al. Effect of oral \u03b2-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study. Crit Care. 2010;14(6):R198. https:\/\/doi.org\/10.1186\/cc9317.","journal-title":"Crit Care"},{"issue":"5","key":"6200_CR51","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jjcc.2019.05.012","volume":"74","author":"T Yamashita","year":"2019","unstructured":"Yamashita T, Nakasu Y, Mizutani H, Sumitani K. A prospective observational survey on landiolol in atrial fibrillation\/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey. J Cardiol. 2019;74(5):418\u201325. https:\/\/doi.org\/10.1016\/j.jjcc.2019.05.012.","journal-title":"J Cardiol"},{"key":"6200_CR52","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1017\/S1047951125109268","volume":"35","author":"L Sandoval","year":"2025","unstructured":"Sandoval L, Arenz C, Hamann M, Chlench S. An exploratory study of landiolol plus amiodarone versus amiodarone monotherapy in paediatric junctional ectopic tachycardia after surgery. Cardiol Young. 2025;35:1906\u201312. https:\/\/doi.org\/10.1017\/S1047951125109268.","journal-title":"Cardiol Young"},{"issue":"2","key":"6200_CR53","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1536\/ihj.19-420","volume":"61","author":"W Dabrowski","year":"2020","unstructured":"Dabrowski W, Siwicka-Gieroba D, Piasek E, Schlegel TT, Jaroszynski A. Successful Combination of Landiolol and Levosimendan in Patients with Decompensated Heart Failure. Int Heart J. 2020;61(2):384\u20139. https:\/\/doi.org\/10.1536\/ihj.19-420.","journal-title":"Int Heart J"},{"issue":"7","key":"6200_CR54","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1253\/circj.cj-12-0033","volume":"76","author":"S Kobayashi","year":"2012","unstructured":"Kobayashi S, Susa T, Tanaka T, Murakami W, Fukuta S, Okuda S, et al. Low-dose \u03b2 blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure. Circ J. 2012;76(7):1646\u201353. https:\/\/doi.org\/10.1253\/circj.cj-12-0033.","journal-title":"Circ J"},{"key":"6200_CR55","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00134-026-08361-1","volume":"52","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W, M\u00f8ller MH, Alshamsi F, Azevedo LC, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026. Intensive Care Med. 2026;52:863\u2013936. https:\/\/doi.org\/10.1007\/s00134-026-08361-1.","journal-title":"Intensive Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06200-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06200-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06200-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:07:26Z","timestamp":1789553246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06200-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6200"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06200-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9269792\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"FG reported support from AOP Health related to the present manuscript; honoraria for lectures from AOP Health, Baxter, Chiesi, Edwards, Masimo, Orion, OrphaSwisse, and Viatris; participation on a Data Safety Monitoring Board or Advisory Board for AOP Health, Orion and Viatris. BL reported honoraria for lectures and support for attending meetings and\/or travel from AOP Health. MB reported honoraria for lectures and participation on a Data Safety Monitoring Board or Advisory Board for AOP Health. MF reported support related to the present manuscript, honoraria for lectures and payment for expert testimony from AOP Health; participation on a Data Safety Monitoring Board or Advisory Board for AOP Health. MJ received research grants by Baxter and Fresenius. He also received consulting fees from AmPharma, Baxter, Biomerieux, Novartis and Sphingotec and honoraria for lectures from AOP Health, Baxter, Biomerieux and Vantive. DM declares no competing interests. SR received support related to the present manuscript, consulting fees, honoraria for lectures and support for attending meetings and\/pr travel from AOP Health. He also received honoraria for lectures from CSL Behring. MS received support for the present manuscript, grants or contracts, consulting fees, honoraria for lectures, support for attending meetings and\/or travel from AOP Health. He also participated on an Advisory Board for AOP Health and received drugs from AOP Health.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"472"}}